Health researcher receives DKK 7.5 million from the Novo Nordisk Foundation
Helle Terkildsen Maindal, associate professor at the Department of Public Health and research manager at the Steno Diabetes Center Copenhagen, will head a research project for the next five years which aims to prevent type 2 diabetes in vulnerable families. The project receives DKK 7.5 million from The Novo Nordisk Foundation's Research Programme in Nursing.
Just under 2,000 pregnant woman develop gestational diabetes in Denmark each year. They have seven to eight times higher risk than other women of getting type 2 diabetes later in life. Research also shows that their children live with a large overrisk of overweight and type 2 diabetes.
In the research project FACE-IT, which will begin in 2018 and be carried out in the form of a randomised controlled trial with a total of 500 families, Helle Terkildsen Maindal and her fellow researchers will develop a health promotion initiative in collaboration with the mothers from the families concerned.
Helle Terkildsen Maindal expects the project to be able to contribute to making the Danish healthcare system better at reducing the social inequalities in health through prevention and health promotion.
Contact
Associate Professor, PhD, Research Manager Helle Terkildsen Maindal
Aarhus University, Department of Public Health and
The Steno Diabetes Center Copenhagen
Mobile: (+45) 2546 2320
Email: htm@ph.au.dk